Diana Krall leads charity event for VGH & UBC Hospital Foundation to benefit drive for 'made-in-B.C. cures' for blood-related cancers
Diana to be joined by friends Tony Bennett, Elton John, husband Elvis
Costello and former U.S. President William J. Clinton
VANCOUVER, March 7 /CNW/ - Diana Krall and some of the world's most noted
performers and humanitarians will focus the spotlight on fundraising for
VGH & UBC Hospital Foundation to help pioneer "made-in-B.C. cures" for
blood-related cancers and diseases at Vancouver General Hospital. Diana will
be joined by her friends Tony Bennett, Elton John, husband Elvis Costello and
former U.S. President William J. Clinton at a private sold-out black tie
charity benefit concert and auction at the Fairmont Hotel Vancouver on
Sunday, April 23, 2006.
"Care and hope is what we all want to provide for our loved ones," says
Diana Krall. "I'm forever grateful for the tremendous care my mother Adella
received through the Leukemia and Bone Marrow Transplant Program. I'm proud
our efforts will support the vision of the talented team at VGH to find a cure
and bring hope to families everywhere."
"We are extremely fortunate to benefit from the leadership of the Krall
family and the support of Diana's husband and friends. We are at a critical
juncture to establish our hospital as a recognized world leader in hematology
through the creation of a new unique Hematology Clinical Trials Unit at VGH,"
says Dr. Mike Barnett, Head of the VGH and UBC Divisions of Hematology. "This
charity benefit helps propel us forward to deliver unmatched care for people
from across our province while bolstering our drive to pioneer 'made-in-B.C.
cures' for blood diseases."
"It's a true honour for us to receive such enormous support from such a
talented, prestigious and giving group of individuals," says Ron Dumouchelle,
President and CEO, VGH & UBC Hospital Foundation. "Our Foundation is grateful
to Diana and her family and friends, who are helping the world-renowned health
care professionals at our hospitals go from strength to strength and advance
world-class health care for people in British Columbia."
The Division of Hematology and the Leukemia/Bone Marrow Transplant
(L/BMT) Program of British Columbia is world-renowned for its care for people
from across B.C. with cancers of the blood such as leukemia and multiple
myeloma.
The charity benefit is a heartfelt expression of the Krall family's
thanks to the wonderful care her mother received through the L/BMT Program at
VGH. Adella Krall, mother of Diana and Michelle, enjoyed six additional
precious years of life following her 1996 diagnosis of multiple myeloma - an
incurable form of cancer that affects the immune system. Diana's previous five
benefit concerts have collectively raised more than $1.3 million - helping to
purchase the latest, most advanced medical equipment, to support patient
comfort needs and to assist out-of-town L/BMT patients. Since Adella's passing
in May 2002, the Krall family has continued to demonstrate its commitment to
VGH & UBC Hospital Foundation. It is the family's desire to help others living
with multiple myeloma to have the best care possible, to celebrate Adella's
vision of helping L/BMT patients and their families and ultimately, to
contribute to finding a cure.
VGH & UBC Hospital Foundation is a registered charity that raises funding
for the latest, most sophisticated medical equipment, world-class research and
improvements to patient care for Vancouver General Hospital, UBC Hospital, GF
Strong Rehab Centre and Vancouver Coastal Health Research Institute. For more
than 25 years, the Foundation and its donors have been a bridge between the
essential health care governments provide and the most advanced health care
possible.
Donations in support of patient care and research may be sent to VGH &
UBC Hospital Foundation, 855 West 12th Ave. Vancouver, BC V5Z 1M9 or by
calling (604) 875-4676 or made on-line at
www.supportvgh.ca
Background on blood-related cancers
and the Hematology Clinical Trials Unit at VGH
Cancers arising from the blood or bone marrow cells include multiple
myeloma and the various types of leukemia. People with blood or bone marrow
cancers experience a range of symptoms. For example, myeloma affects the
blood, bones, immune system and kidneys, and as a result, patients may suffer
bone pain and fractures, anemia, infection and bleeding, and impairment of
kidney function. A disease of adults, about 200 new cases of myeloma are
diagnosed in B.C. every year.
There are various types of leukemia generally classified as acute
(rapidly growing) or chronic (slowly growing). Approximately 600 individuals
in B.C. develop leukemia each year.
The Vision: "Made in B.C." cures
Leading-edge work is being done in patient care at VGH. With the
Hematology Clinical Trials Unit in place, B.C. patients will be able to
participate in clinical trials of the latest treatments developed in-house at
VGH, accessing new, effective, and less-toxic therapies long before they are
widely available. Ultimately, the vision is to find a cure for blood diseases
here in B.C.
The Division of Hematology plans to build on its strengths to become a
national and international leader in bringing new treatments to patients as
quickly as possible. One of the main obstacles to the progress of promising
new treatments is the amount of time required to take protocols through the
necessary approval process, manage documents such as consent forms, monitor
patients on treatment as well as collect and evaluate data. The Clinical
Trials Unit will provide the support needed to speed up this process.
Implementation of the Hematology Clinical Trials Unit began with the
recruitment of key research staff in the fall of 2005, thanks to the generous
support of donors and further bolstered by the Diana Krall & Friends Charity
Benefit. A further investment of $6 million is required to increase research
capacity by purchasing equipment and technology, hiring additional research
staff, establishing fellowships, and attracting a leading researcher to hold
the position of Director, Thrombosis. This fundraising goal includes an
endowment to ensure sustainability of the Clinical Trials Unit.
In the summer of 2006, the unit will be moved to a new location in the
Ambulatory Care Centre, currently under construction at Oak Street and West
12th Avenue.
http://www.supportvgh.ca/index.cfm?fuseaction=pub.myDocumentViewer&type=newsletter&childId=176&skin=InTheNews